GLP1R and retinal disorder: Patients who prescribed a GLP-1 RA had higher prevalence of diabetes chronic complications (retinopathy: 16.1% vs 9.9%; neuropathy: 40.9% vs 27.6%) compared with the overall cohort (Table 3).